Advanced Therapy Medicinal Products Market
According to Intent Market Research, the Advanced Therapy Medicinal Products Market is expected to grow from USD 28.5 billion in 2023 at a CAGR of 16.9% to touch USD 85.1 billion by 2030. The Advanced Therapy Medicinal Products Market is dominated by key players such as Gilead Sciences, Inc., Novartis AG, Pfizer Inc., Sangamo Therapeutics, Inc., Bluebird Bio, Inc., Bayer AG, Celgene Corporation (Bristol-Myers Squibb), Boehringer Ingelheim GmbH, AbbVie Inc., Orchard Therapeutics, Lonza Group, Kite Pharma (Gilead Sciences), Medtronic PLC, Editas Medicine, Autolus Therapeutics